James B Bucher - Net Worth and Insider Trading

James B Bucher Net Worth

The estimated net worth of James B Bucher is at least $185,194 dollars as of 2025-05-02. James B Bucher is the EVP & General Counsel of Alder BioPharmaceuticals Inc and owns about 9,809 shares of Alder BioPharmaceuticals Inc (ALDR) stock worth over $185,194. Details can be seen in James B Bucher's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James B Bucher has not made any transactions after 2019-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of James B Bucher

To

James B Bucher Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James B Bucher owns 1 companies in total, including Climb Bio Inc (CLYM) .

Click here to see the complete history of James B Bucher’s form 4 insider trades.

Insider Ownership Summary of James B Bucher

Ticker Company Transaction Date Type of Owner
CLYM Climb Bio Inc 2021-08-09 EVP and General Counsel

James B Bucher Latest Holdings Summary

James B Bucher currently owns a total of 1 stock. James B Bucher owns 9,809 shares of Alder BioPharmaceuticals Inc (ALDR) as of April 25, 2019, with a value of $185,194.

Latest Holdings of James B Bucher

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALDR Alder BioPharmaceuticals Inc 2019-04-25 9,809 18.88 185,194

Holding Weightings of James B Bucher


James B Bucher Form 4 Trading Tracker

According to the SEC Form 4 filings, James B Bucher has made a total of 0 transactions in Alder BioPharmaceuticals Inc (ALDR) over the past 5 years. The most-recent trade in Alder BioPharmaceuticals Inc is the sale of 1,897 shares on April 25, 2019, which brought James B Bucher around $26,274.

Insider Trading History of James B Bucher

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James B Bucher Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James B Bucher Ownership Network

Ownership Network List of James B Bucher

No Data

Ownership Network Relation of James B Bucher

Insider Network Chart

James B Bucher Owned Company Details

What does Climb Bio Inc do?

Who are the key executives at Climb Bio Inc?

James B Bucher is the EVP and General Counsel of Climb Bio Inc. Other key executives at Climb Bio Inc include Chief Accounting Officer Emily Pimblett , Chief Scientific Officer Valerie Morisset , and director & 10 percent owner Ra Capital Healthcare Fund Lp .

Climb Bio Inc (CLYM) Insider Trades Summary

Over the past 18 months, James B Bucher made no insider transaction in Climb Bio Inc (CLYM). Other recent insider transactions involving Climb Bio Inc (CLYM) include a net sale of 481,639 shares made by Valerie Morisset , a net sale of 4,870 shares made by Emily Pimblett , and a net purchase of 13,008,546 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 1,199 shares of Climb Bio Inc (CLYM) in total and bought 0 shares, with a net sale of 1,199 shares. During the past 18 months, 486,509 shares of Climb Bio Inc (CLYM) were sold and 13,008,546 shares were bought by its insiders, resulting in a net purchase of 12,522,037 shares.

Climb Bio Inc (CLYM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Climb Bio Inc Insider Transactions

No Available Data

James B Bucher Mailing Address

Above is the net worth, insider trading, and ownership report for James B Bucher. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, James B Bucher's mailing address is: Bothell Wa 98011.